Taiwan FDA registration 636faac0b9b3cce05d330fc8f6396d71
RAMP Myoglobin Assay
TW: “倫普” 肌紅蛋白檢驗試劑組
Taiwan·Risk Class 2·MD·RESPONSE BIOMEDICAL CORPORATION·Registered Nov 17, 2015 – Nov 17, 2025ExpiredRegistration details
- Analysis ID
- 636faac0b9b3cce05d330fc8f6396d71
- License Form
- Ministry of Health Medical Device Import No. 027907
- Customs Code
- DHA05602790701
Company information
- Manufacturer
- RESPONSE BIOMEDICAL CORPORATION
- Manufacturer Country
- Canada
- Authorized Representative
- RECHI CO., LTD.
Product details
- Intended Use
- This product is a quantitative immunochromochromatography method used in conjunction with the RAMP Reader System or RAMP 200 System in vitro diagnostic products for the detection of Myoglabrobin concentration in EDTA whole blood.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C5680 Myoglobin immunoassay system
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Nov 17, 2015
- Expiry Date
- Nov 17, 2025
About this record
Access comprehensive regulatory information for RAMP Myoglobin Assay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 636faac0b9b3cce05d330fc8f6396d71 and manufactured by RESPONSE BIOMEDICAL CORPORATION. The authorized representative in Taiwan is RECHI CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices